Detalhe da pesquisa
1.
DNA hypomethylation leads to cGAS-induced autoinflammation in the epidermis.
EMBO J;
40(22): e108234, 2021 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34586646
2.
Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils.
J Allergy Clin Immunol;
151(1): 202-211, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35953001
3.
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosis.
Blood;
137(15): 2070-2084, 2021 04 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33512435
4.
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.
Am J Hematol;
98(5): 770-783, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36814396
5.
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.
Am J Hematol;
97(4): 390-400, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35015307
6.
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia.
Am J Hematol;
97(9): 1215-1225, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35794848
7.
Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms.
Semin Cancer Biol;
60: 191-201, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31408723
8.
CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis.
Blood;
132(18): 1936-1950, 2018 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30018080
9.
Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis.
Haematologica;
105(2): 366-374, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31018976
10.
CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis.
Blood;
129(3): 371-382, 2017 01 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27856463
11.
Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML.
Int J Mol Sci;
20(17)2019 Aug 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31470642
12.
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.
Haematologica;
103(5): 799-809, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29439183
13.
Human skin dendritic cell fate is differentially regulated by the monocyte identity factor Kruppel-like factor 4 during steady state and inflammation.
J Allergy Clin Immunol;
139(6): 1873-1884.e10, 2017 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27742396
14.
Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.
Blood;
126(26): 2832-41, 2015 Dec 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26486787
15.
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia.
Haematologica;
102(9): 1519-1529, 2017 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28596283
16.
Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage.
Ann Hematol;
94(2): 223-31, 2015 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25209843
17.
DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.
Eur J Clin Invest;
44(12): 1239-45, 2014 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25371066
18.
Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.
Am J Cancer Res;
13(2): 355-378, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36895976
19.
CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.
Leukemia;
37(11): 2250-2260, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37673973
20.
Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph+ Chronic Myeloid Leukemia.
Cells;
12(1)2022 12 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36611797